Imagion Biosystems has released “Preliminary Report and Appendix 4E for the year ended 31 December 2018.
View Appendix 4E and Preliminary Report.
Positive independent review sets priority path to market for MagSense® Technology
Highlights Blinded review by panel of expert breast radiologists corroborates potential for MagSense® nanoparticle technology to detect tumour cells in lymph nodes by Magnetic Resonance